ArticleJournal of the International AIDS Society2014

Potential implications of CYP3A4, CYP3A5 and MDR-1 genetic variants on the efficacy of Lopinavir/Ritonavir (LPV/r) monotherapy in HIV-1 patients.

Giulia Berno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.